Volume 119, Issue 4, Pages (October 2000)

Slides:



Advertisements
Similar presentations
Celiac disease–like abnormalities in a subgroup of patients with irritable bowel syndrome Ulrich Wahnschaffe, R. Ullrich, E.O. Riecken, J.D. Schulzke Gastroenterology.
Advertisements

Overview and pathogenesis of celiac disease Martin F. Kagnoff Gastroenterology Volume 128, Issue 4, Pages S10-S18 (April 2005) DOI: /j.gastro
Interleukin 15 mediates epithelial changes in celiac disease Luigi Maiuri, Carolina Ciacci, Salvatore Auricchio, Virginia Brown, Sonia Quaratino, Marco.
Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease Richard N. Fedorak, *, Alfred Gangl, ‡, Charles.
Imaging of perianal Crohn's disease S. Ardizzone, G. Maconi, A. Cassinotti, A. Massari, G. Bianchi Porro Digestive and Liver Disease Volume 39, Issue 10,
Masatoshi Kudo  Clinical Gastroenterology and Hepatology 
It's time to bring the best and brightest back to gastroenterology!
Charlotte de Bie, Angelika Kindermann, Johanna Escher 
Volume 122, Issue 1, Pages (January 2002)
Volume 119, Issue 4, Pages (October 2000)
Volume 123, Issue 4, Pages (October 2002)
Volume 145, Issue 4, Pages e1 (October 2013)
Volume 122, Issue 3, Pages (March 2002)
Diagnosis of irritable bowel syndrome
Leptin, obesity, and liver disease
Volume 122, Issue 1, Pages (January 2002)
Systematic review of the comorbidity of irritable bowel syndrome with other disorders: What are the causes and implications?  William E. Whitehead, Olafur.
Polyxeni Koutkia, Zhiren Lu, Tai C. Chen, Michael F. Holick 
Volume 124, Issue 4, Pages (April 2003)
Milen Pavlović, Nebojša Jović, Tatjana Pekmezović 
Milen Pavlović, Nebojša Jović, Tatjana Pekmezović 
Spreading and focusing of gluten epitopes in celiac disease
Volume 120, Issue 6, Pages (May 2001)
Hepatitis B infection in heart transplant recipients
Volume 119, Issue 4, Pages (October 2000)
Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients  David Schoemaker, Robert Black, Lynne.
Appendectomy is followed by increased risk of Crohn's disease
Diagnosing autoimmune hepatitis in children: Is the International Autoimmune Hepatitis Group scoring system useful?  Regan L. Ebbeson, Richard A. Schreiber 
Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C  Chi–Jen Chu, Munira Hussain,
Randomized controlled trial of duration of analgesia following intravenous or rectal acetaminophen after adenotonsillectomy in children  F. Capici, P.M.
Leigh Ann White, Joseph Menzin, Jonathan R
Antje Timmer*, Lloyd R. Sutherland*,‡, Francois Martin§ 
Miguel Regueiro, Kevin E. Kip, Leonard Baidoo, Jason M
Volume 120, Issue 4, Pages (March 2001)
Volume 123, Issue 2, Pages (August 2002)
Volume 121, Issue 3, Pages (September 2001)
Volume 119, Issue 1, Pages (July 2000)
Volume 122, Issue 7, Pages (June 2002)
Long-term mortality following bloodstream infection
Volume 133, Issue 2, Pages (August 2007)
Lise L. Kjaergard, Sarah L. Frederiksen, Christian Gluud 
AGA technical review on nonalcoholic fatty liver disease
Corticosteroid Therapy in the Age of Infliximab: Acute and 1-Year Outcomes in Newly Diagnosed Children With Crohn’s Disease  James Markowitz, Jeffrey.
Volume 73, Issue 10, Pages (May 2008)
Volume 114, Issue 6, Pages (June 1998)
Budesonide versus mesalamine for maintaining remission in patients refusing other immunomodulators for steroid-dependent Crohn's disease  Gerassimos J.
Volume 121, Issue 5, Pages (November 2001)
Image of the month Gastroenterology
Volume 121, Issue 5, Pages (November 2001)
Increased intestinal permeability precedes the onset of Crohn's disease in a subject with familial risk  E.Jan Irvine, John K. Marshall  Gastroenterology 
Volume 122, Issue 3, Pages (March 2002)
Volume 121, Issue 5, Pages (November 2001)
AGA technical review on osteoporosis in gastrointestinal diseases
Volume 117, Issue 3, Pages (September 1999)
Volume 122, Issue 4, Pages (April 2002)
Volume 128, Issue 7, Pages (June 2005)
Volume 132, Issue 3, Pages (March 2007)
The North American Study for the Treatment of Refractory Ascites
Mesalamine and relapse prevention in Crohn's disease
Michelle Maria Pietzak  Gastroenterology 
This Month in AJKD American Journal of Kidney Diseases
Bruce G. Bender, PhD, Alex Pedan, PhD, Laleh T. Varasteh, RPh, MSF 
Volume 123, Issue 3, Pages (September 2002)
Masatoshi Kudo  Clinical Gastroenterology and Hepatology 
Volume 121, Issue 4, Pages (October 2001)
Supplemental Fig 1 (A) (B) (B) 59% % alive 52% Years from entry 59%
Predictors of response to infliximab in patients with Crohn's disease
Medical Therapy for Refractory Pediatric Crohn’s Disease
Outcomes among Patients with Recurrent High-Risk Hematologic Malignancies after Allogeneic Hematopoietic Cell Transplantation  Marco Mielcarek, Barry.
This Month in AJKD American Journal of Kidney Diseases
Presentation transcript:

Volume 119, Issue 4, Pages 895-902 (October 2000) A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease  James Markowitz, Kathy Grancher, Nina Kohn, Martin Lesser, Fredric Daum  Gastroenterology  Volume 119, Issue 4, Pages 895-902 (October 2000) DOI: 10.1053/gast.2000.18144 Copyright © 2000 American Gastroenterological Association Terms and Conditions

Fig. 1 Time (days) off of corticosteroid treatment after initial discontinuation, depicted as a Kaplan–Meier survival curve. ■, 6-MP; ▴, controls. P < 0.0001. Gastroenterology 2000 119, 895-902DOI: (10.1053/gast.2000.18144) Copyright © 2000 American Gastroenterological Association Terms and Conditions

Fig. 2 Cumulative prednisone dose (mean ± SD). All subjects who withdrew from the study had their last prednisone doses carried forward to the conclusion of the 18-month study period. ▨ , 6-MP (n = 27); ■, controls (n = 28). *P < 0.02; **P < 0.004. Gastroenterology 2000 119, 895-902DOI: (10.1053/gast.2000.18144) Copyright © 2000 American Gastroenterological Association Terms and Conditions

Fig. 3 Cumulative prednisone dose (mean ± SD) actually taken by subjects in both groups from day of entry into the study until completion of the 18-month treatment period or until withdrawal. ▨ , 6-MP (n = 27); ■, controls (n = 28). *P < 0.03; **P < 0.007; ***P < 0.008. Gastroenterology 2000 119, 895-902DOI: (10.1053/gast.2000.18144) Copyright © 2000 American Gastroenterological Association Terms and Conditions

Fig. 4 Kaplan–Meier survival curve of relapse-free duration of remission. ■, 6-MP; ▴, controls. P < 0.007. Gastroenterology 2000 119, 895-902DOI: (10.1053/gast.2000.18144) Copyright © 2000 American Gastroenterological Association Terms and Conditions